The Scientific Foundation of the Spanish Association Against Cancer has created its own research centre accreditation system to ‘promote excellence i1
The Journal of Hepatology has published a study led by Josep M Llovet’s team at IDIBAPS-Hospital Clínic identifying the molecular characteristics ass1
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cance1
Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to impr1
On Monday 24 February, the Spanish Association Against Cancer (AECC) held a ceremony to announce the research grants awarded in Barcelona during 20241
A new study published in the journal Nature, with the participation of Josep M Llovet and four members of his team at Hospital Clínic-IDIBAPS, descri1
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. Inv1
Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most inf1
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to conduct1
